Filtered coffee shows a causal link to healthier HbA1c levels
A large genetic study reveals that how coffee is prepared matters, linking filtered coffee to improved glycaemic control…
AI model identifies prediabetes risk with high accuracy
By combining oxidative stress biology with advanced machine learning, researchers show how a simple blood-based antioxidant measure can…
Researchers unravel why mRNA-based vaccines for COVID-19 can cause heart damage
Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage…
Gut microbe metabolite TMA improves blood sugar by shutting down a key inflammatory switch
A microbial metabolite long linked to cardiovascular risk emerges as a surprising ally against metabolic inflammation, revealing how…
Collagen Production and Skin Renewal Directly Respond to Amount of Vitamin C We Consume: Study
Skin vitamin C levels are closely tied to levels of the vitamin in the blood (plasma) and can…
Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis
Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve…
Routine blood test may flag hidden osteoporosis risk, study finds
Common blood test results may offer an early clue to bone loss, suggesting that alkaline phosphatase levels could…
Timing of genetic mutation dictates childhood leukemia aggressiveness
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with…
Simple blood and urine tests could spare febrile infants from more invasive procedures
New evidence from a six-country study led by the Montreal Children’s Hospital and Children’s National Hospital shows simple…
Noninvasive Raman device tracks blood glucose accurately in under a minute
A shoebox-sized optical device reads glucose directly through the skin in seconds, offering a promising step toward truly…
Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALL
A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic…
Aza-ven shows superior outcomes compared to induction chemotherapy in AML patients
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined…